Characteristic brain distribution of 1-14C-Octanoate in a rat model of focal cerebral ischemia in comparison with those of 123I-IMP and 123I-Iomazenil

Journal of Nuclear Medicine

Volumn 44, Issue 7, 2003, Pages 1168-1175

  Kuge, Yuji ^a   Hikosaka, Kenji ^a,b   Seki, Koh Ichi ^b   Ohkura, Kazue ^b   Nishijima, Ken Ichi ^a,b   Kaji, Tomohito ^a   Ueno, Satoshi ^a   Tsukamoto, Eriko ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

1 11C octanoate; Cerebral blood flow; Cerebral ischemia; Glial function; Neuronal function

Indexed keywords

CARBON 14; EOSIN; FATTY ACID; HEMATOXYLIN; IODINE 123; IOMAZENIL; OCTANOIC ACID DERIVATIVE; DRUG DERIVATIVE; FLUMAZENIL; IOFETAMINE; OCTANOIC ACID; RADIOPHARMACEUTICAL AGENT;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; BRAIN SLICE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FATTY ACID METABOLISM; HEMISPHERE; MACROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; DISEASE MODEL; EVALUATION; METABOLISM; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; VALIDATION STUDY;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FLUMAZENIL; IOFETAMINE; OCTANOIC ACIDS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0041386137     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Heiss W-D, Herholz K. Assessment of pathophysiology of stroke by positron emission tomography. Eur J Nucl Med. 1994;21:455-465.
2. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci. 1996;16:877-885.
3. Magistretti PJ, Pellerin L. Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex. 1996;6:50-61.
4. Magistretti PJ, Pellerin L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci. 1999;14:177-182.
5. Araque A, Carmignoto G, Haydon PG. Dynamic signaling between astrocytes and neurons. Annu Rev Physiol. 2001;63 795-813.
6. Zoli M, Grimaldi R, Ferrari R, Zini I, Agnati LF. Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats. Stroke. 1997,28:1049-1059.
7. Louw DF, Masada T, Sutherland GR. Ischemic neuronal injury is ameliorated by astrocyte activation. Can J Neurol Sci. 1998;25:102-107.
8. Muir D, Berl S, Clarke DD. Acetate and fluoroacetate as possible markers for glial metabolism in vivo. Brain Res. 1986,380:336-340
9. Oldendorf WH Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol. 1973;224:1450-1453.
10. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture J Neurochem. 1991,56 1376-1386.
11. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes and oligodendrocytes from developing brain in primary culture. J Neurosci Res. 1987;18:551-561
12. Edmond J. Energy metabolism in developing brain cells. Can J Physiol Pharmacol 1992;70:S118-S129.
13. Cremer SE, Teal HM, Heath DF, Cavanagh JB, The influence of portacaval anastomosis on the metabolism of labelled octanoate, butyrate and leucine in rat brain. J Neurochem 1977;28:215-222.
14. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 1979;161:303-310.
15. 11C]octanoate in rats: pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism. Ann Nucl Med. 1995;9:137-142.
16. Berl S, Clarke DD Compartmentation of amino acid metabolism. In: Lajtha A, ed Handbook of Neurochemistry. Vol 2. New York, NY. Plenum; 1969:447-472.
17. 14C]Octanoate. a fast functional marker of brain activity. Brain Res. 1985,335 326-329.
18. Spector R. Fatty acid transport through the blood-brain barrier. J Neurochem. 1988;50:639-643.
19. 11C]octanoate as a PET tracer Ann Nucl Med. 1996;10:395-399.
20. 11C]octanoate as a PET tracer of glial functions. Nucl Med Biol. 2002,29:303-306.
21. 11C]-3-(R, S)-methyloctanoic acid as potential markers for PET studies of fatty acid metabolism. J Labelled Compds Radiopharm. 1997;39:181-193.
22. 11C]octanoate analogs in rats and a cat Nucl Med Biol. 1998;25 543-548.
23. 11C]Octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats. Nucl Med Biol. 1996;23:1009-1012
24. 11C]octanoate as a PET tracer for studying cerebral ischemia. Ann Nucl Med. 2000;14:69-74.
25. 11C]Octanoate as a PET tracer for studying ischemic stroke: evaluation in a canine model of thromboembolic stroke with positron emission tomography Biol Pharm Bull. 2000;23:984-988.
26. 123I]iodoamphetamine (IMP) tomography. J Nucl Med 1982;23:196-203.
27. 125I-labeled iodobenzodiazepines. Appl Radiat Isot. 1991;42:173-175.
28. Longa EZ, Weinstein PR, Carlson S, Cummins R Reversible middle cerebral artery occlusion without craniectomy in rats Stroke. 1989,20:84-91.
29. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS Diffusion-weighted magnetic resonance imaging rapid and quantitative detection of focal brain ischemia Neurology. 1992;42:235-240
30. Kuge Y, Minematsu K, Yamaguchi T, Miyake Y. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats. Stroke 1995;26:1655-1658.
31. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy Stroke. 2000;31 366-369.
32. Garcia JH, Liu KF, Ho KL. Neuronal necrosis after middle cerebral arten occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke. 1995;26:636-642.
33. Watanabe Y, Nakano T, Yutani K, et al. Detection of viable cortical neurons using benzodiazepine receptor imaging after reversible focal ischaemia in rats: comparison with regional cerebral blood flow. Eur J Nucl Med. 2000;27:308-313.
34. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307-310.
35. 125I-iomazenil and 99Tcm-HMPAO in experimental brain ischaemia. Nucl Med Commun. 1995;16:581-590.
36. Hatazawa J, Satoh T, Shimosegawa E, et al. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT. J Nucl Med. 1995;36:2154-2161.
37. Toyama H, Matsumura K, Nakashima H, et al. Characterization of neuronal damage by iomazenil binding and cerebral blood flow in an ischemic rat model. Ann Nucl Med. 1998;12:267-273
38. Lassen NA. Incomplete cerebral infarction: focal incomplete ischemic tissue necrosis not leading to emollision Stroke. 1982;13:522-523
39. Marcoux FW, Morawetz RB, Crowell RM, DeGirolami U, Halsey JH Jr. Differential regional vulnerability in transient focal cerebral ischemia. Stroke. 1982, 13:339-346.
40. Garcia JH, Kamijyo Y Cerebral infarction: evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol. 1974;33:408-421.